| Parnax Lab Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 506128 |
NSE Symbol : - |
P/E(TTM) : 74.70 |
|
ISIN Demat : INE383L01019 |
Div & Yield% : - |
EPS(TTM) : 2.16 |
|
Book Value(₹) : 19.57 |
Market Cap(₹Cr) : 185.32 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 1.54 | 3.66 | 1.71 | 2.77 | 1.83 | 1.13 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 1.54 | 3.66 | 1.71 | 2.77 | 1.83 | 1.13 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.18 | 0.17 | 0.11 | 0.12 | 0.18 | 0.11 |
| Total Income | 1.72 | 3.83 | 1.82 | 2.89 | 2.01 | 1.25 |
| Total Expenditure | 1.34 | 2.41 | 1.55 | 1.54 | 1.13 | 1.11 |
| PBIDT | 0.38 | 1.43 | 0.27 | 1.36 | 0.88 | 0.14 |
| Interest | 0.00 | 0.01 | 0.02 | 0.01 | 0.07 | 0.04 |
| PBDT | 0.38 | 1.42 | 0.26 | 1.34 | 0.81 | 0.10 |
| Depreciation | 0.02 | 0.02 | 0.01 | 0.01 | 0.02 | 0.01 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.09 | 0.35 | 0.07 | 0.34 | 0.19 | 0.02 |
| Reported Profit After Tax | 0.27 | 1.05 | 0.17 | 0.99 | 0.60 | 0.07 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 0.27 | 1.05 | 0.17 | 0.99 | 0.60 | 0.07 |
| EPS (Unit Curr.) | 0.24 | 0.91 | 0.15 | 0.86 | 0.52 | 0.06 |
| EPS (Adj) (Unit Curr.) | 0.24 | 0.91 | 0.15 | 0.86 | 0.52 | 0.06 |
| Calculated EPS (Unit Curr.) | 0.24 | 0.91 | 0.15 | 0.86 | 0.52 | 0.06 |
| Calculated EPS (Adj) (Unit Curr.) | 0.24 | 0.91 | 0.15 | 0.86 | 0.52 | 0.06 |
| Calculated EPS (Ann.) (Unit Curr.) | 0.94 | 3.66 | 0.60 | 3.44 | 2.08 | 0.23 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 0.94 | 3.66 | 0.60 | 3.44 | 2.08 | 0.23 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 11.49 | 11.49 | 11.49 | 11.49 | 11.49 | 11.49 |
| Reserve & Surplus | 10.99 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 24.68 | 39.07 | 15.79 | 49.10 | 48.09 | 12.39 |
| PBDTM(%) | 24.68 | 38.80 | 15.20 | 48.38 | 44.26 | 8.85 |
| PATM(%) | 17.53 | 28.69 | 9.94 | 35.74 | 32.79 | 6.19 |